SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AXA S.A. (AXAHY) trades at a trailing P/E of 11.0, forward P/E of 12.0. Trailing earnings yield is 9.12%, forward earnings yield 8.34%. PEG 0.37 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (11.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.37); earnings yield beats bond yields (9.12%).
- PEG Ratio 0.37 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.12% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 78/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AXAHY
Valuation Multiples
P/E (TTM)11.0
Forward P/E12.0
PEG Ratio0.37
Forward PEG2.31
P/B Ratio0.00
P/S Ratio0.93
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.50
Forward EPS (Est.)$4.11
Book Value / Share$0.00
Revenue / Share$53.08
FCF / Share$0.00
Yields & Fair Value
Earnings Yield9.12%
Forward Earnings Yield8.34%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.30 |
$121.8B |
$5.56B |
4.6% |
| 2017 |
$2.49 |
$128.42B |
$5.98B |
4.7% |
| 2018 |
$0.79 |
$100.93B |
$1.88B |
1.9% |
| 2019 |
$1.51 |
$124.94B |
$3.86B |
3.1% |
| 2020 |
$1.25 |
$102.58B |
$3.16B |
3.1% |
| 2021 |
$2.97 |
$111.69B |
$7.29B |
6.5% |
| 2022 |
$2.12 |
$93.08B |
$6.68B |
7.2% |
| 2023 |
$3.13 |
$87.15B |
$7.19B |
8.2% |
| 2024 |
$3.47 |
$89.82B |
$7.89B |
8.8% |
| 2025 |
$4.50 |
$110.96B |
$9.41B |
8.5% |
